To clarify the role of UBL3 as a PTM factor, we expressed Flag-UBL3 in MDA-MB-231 breast cancer cells and purified UBL3 proteins by immunoprecipitation, followed by western blotting with UBL3 antiserum. This evidence concerns the gene UBL3 and breast carcinoma.